Cargando…
COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis?
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Global Health
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344979/ https://www.ncbi.nlm.nih.gov/pubmed/35916589 http://dx.doi.org/10.7189/jogh.12.03055 |
| _version_ | 1784761330818875392 |
|---|---|
| author | Akande, Oluwatosin Wuraola Igumbor, Ehimario Uche Elimian, Kelly Osezele Ohonsi, Cornelius Ehizokhai Nwozor, Lilian Oden, Okanke Ekpenyong, Emmanuel Nsa Ndodo, Nnaemeka Ike, Ifeanyi F Egede, Magdalene Nwachukwu, William Onoja, Amedu M Fofah, Jenson Gawain Azi, Reuben Ishiaku Ochu, Chinwe L Adetifa, Ifedayo M |
| author_facet | Akande, Oluwatosin Wuraola Igumbor, Ehimario Uche Elimian, Kelly Osezele Ohonsi, Cornelius Ehizokhai Nwozor, Lilian Oden, Okanke Ekpenyong, Emmanuel Nsa Ndodo, Nnaemeka Ike, Ifeanyi F Egede, Magdalene Nwachukwu, William Onoja, Amedu M Fofah, Jenson Gawain Azi, Reuben Ishiaku Ochu, Chinwe L Adetifa, Ifedayo M |
| author_sort | Akande, Oluwatosin Wuraola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9344979 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | International Society of Global Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93449792022-08-10 COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis? Akande, Oluwatosin Wuraola Igumbor, Ehimario Uche Elimian, Kelly Osezele Ohonsi, Cornelius Ehizokhai Nwozor, Lilian Oden, Okanke Ekpenyong, Emmanuel Nsa Ndodo, Nnaemeka Ike, Ifeanyi F Egede, Magdalene Nwachukwu, William Onoja, Amedu M Fofah, Jenson Gawain Azi, Reuben Ishiaku Ochu, Chinwe L Adetifa, Ifedayo M J Glob Health Viewpoints International Society of Global Health 2022-08-03 /pmc/articles/PMC9344979/ /pubmed/35916589 http://dx.doi.org/10.7189/jogh.12.03055 Text en Copyright © 2022 by the Journal of Global Health. All rights reserved. https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License. |
| spellingShingle | Viewpoints Akande, Oluwatosin Wuraola Igumbor, Ehimario Uche Elimian, Kelly Osezele Ohonsi, Cornelius Ehizokhai Nwozor, Lilian Oden, Okanke Ekpenyong, Emmanuel Nsa Ndodo, Nnaemeka Ike, Ifeanyi F Egede, Magdalene Nwachukwu, William Onoja, Amedu M Fofah, Jenson Gawain Azi, Reuben Ishiaku Ochu, Chinwe L Adetifa, Ifedayo M COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis? |
| title | COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis? |
| title_full | COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis? |
| title_fullStr | COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis? |
| title_full_unstemmed | COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis? |
| title_short | COVID-19 vaccine effectiveness studies in Nigeria: Quo vadis? |
| title_sort | covid-19 vaccine effectiveness studies in nigeria: quo vadis? |
| topic | Viewpoints |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344979/ https://www.ncbi.nlm.nih.gov/pubmed/35916589 http://dx.doi.org/10.7189/jogh.12.03055 |
| work_keys_str_mv | AT akandeoluwatosinwuraola covid19vaccineeffectivenessstudiesinnigeriaquovadis AT igumborehimariouche covid19vaccineeffectivenessstudiesinnigeriaquovadis AT elimiankellyosezele covid19vaccineeffectivenessstudiesinnigeriaquovadis AT ohonsicorneliusehizokhai covid19vaccineeffectivenessstudiesinnigeriaquovadis AT nwozorlilian covid19vaccineeffectivenessstudiesinnigeriaquovadis AT odenokanke covid19vaccineeffectivenessstudiesinnigeriaquovadis AT ekpenyongemmanuelnsa covid19vaccineeffectivenessstudiesinnigeriaquovadis AT ndodonnaemeka covid19vaccineeffectivenessstudiesinnigeriaquovadis AT ikeifeanyif covid19vaccineeffectivenessstudiesinnigeriaquovadis AT egedemagdalene covid19vaccineeffectivenessstudiesinnigeriaquovadis AT nwachukwuwilliam covid19vaccineeffectivenessstudiesinnigeriaquovadis AT onojaamedum covid19vaccineeffectivenessstudiesinnigeriaquovadis AT fofahjensongawain covid19vaccineeffectivenessstudiesinnigeriaquovadis AT azireubenishiaku covid19vaccineeffectivenessstudiesinnigeriaquovadis AT ochuchinwel covid19vaccineeffectivenessstudiesinnigeriaquovadis AT adetifaifedayom covid19vaccineeffectivenessstudiesinnigeriaquovadis |